HOSPITALIZATION PATTERNS AND RESOURCE UTILIZATION AT THE LVIV REGIONAL CLINICAL INFECTIOUS DISEASES HOSPITAL: A 2025 RETROSPECTIVE ANALYSIS
Author(s)
Nadiya Prykuda, PhD1, Serhii Fedorenko, Dr2, Andrii Zadorozhnyi3, Olha Zaliska, ScD, PharmD, PhD1.
1Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, 2Communal Non-Profit Enterprise of Lviv Regional Council "Lviv Regional Clinical Infectious Diseases Hospital", Lviv, Ukraine., Lviv, Ukraine, 3Associate Professor, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
1Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, 2Communal Non-Profit Enterprise of Lviv Regional Council "Lviv Regional Clinical Infectious Diseases Hospital", Lviv, Ukraine., Lviv, Ukraine, 3Associate Professor, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
OBJECTIVES: To evaluate the structure of morbidity, hospital resource utilization (length of stay-number of bed-days), and treatment outcomes across major disease categories at a specialized regional infectious disease center, focusing on the burden of infectious and respiratory diseases in the post-pandemic era.
METHODS: A retrospective descriptive analysis of hospital administrative data (Form 3220) was conducted for the 12 months during 2025 year at the "Lviv Regional Clinical Infectious Diseases Hospital". The study population included all patients admitted to the inpatient department. Data were stratified by ICD-10 chapters and age groups (adults ≥18 years and children <18 years). Key outcome measures included the number of admissions, total bed-days utilized, average length of stay (ALOS), and in-hospital mortality.
RESULTS: In 2025, the facility recorded 1,914 total admissions (1,813 adults and 101 children). The total resource consumption for adults was 19,403 bed-days with a low overall mortality rate of 0.22% (n=4). Infectious and parasitic diseases (A00-B97) were the primary driver of adult healthcare utilization, accounting for 59.6% of admissions (n=1,081) and 54.8% of total bed-days (10,639), with an implied ALOS of 9.8 days. Respiratory diseases (J00-J99) ranked second, comprising 28.8% of adult admissions (n=522) and 4,809 bed-days. Notably, COVID-19 (U07.1) accounted for 11.5% of the total adult caseload (n=208). While diseases of the circulatory system (I00-I99) represented only 3.4% of admissions (n=61), they required disproportionately high resources (2,078 bed-days). Pediatric admissions (n=101) were almost exclusively driven by respiratory (51.5%) and infectious (46.5%) conditions.
CONCLUSIONS: Infectious and respiratory diseases continue to represent the dominant burden on hospital capacity at the “Lviv Regional Clinical Infectious Diseases Hospital”. While the volume of circulatory disease patients is lower, their high resource consumption per capita highlights a specific area for effectiveness optimization. The persistence of COVID-19 admissions in 2025 underscores the need for continued infectious disease management strategies and cost evaluation.
METHODS: A retrospective descriptive analysis of hospital administrative data (Form 3220) was conducted for the 12 months during 2025 year at the "Lviv Regional Clinical Infectious Diseases Hospital". The study population included all patients admitted to the inpatient department. Data were stratified by ICD-10 chapters and age groups (adults ≥18 years and children <18 years). Key outcome measures included the number of admissions, total bed-days utilized, average length of stay (ALOS), and in-hospital mortality.
RESULTS: In 2025, the facility recorded 1,914 total admissions (1,813 adults and 101 children). The total resource consumption for adults was 19,403 bed-days with a low overall mortality rate of 0.22% (n=4). Infectious and parasitic diseases (A00-B97) were the primary driver of adult healthcare utilization, accounting for 59.6% of admissions (n=1,081) and 54.8% of total bed-days (10,639), with an implied ALOS of 9.8 days. Respiratory diseases (J00-J99) ranked second, comprising 28.8% of adult admissions (n=522) and 4,809 bed-days. Notably, COVID-19 (U07.1) accounted for 11.5% of the total adult caseload (n=208). While diseases of the circulatory system (I00-I99) represented only 3.4% of admissions (n=61), they required disproportionately high resources (2,078 bed-days). Pediatric admissions (n=101) were almost exclusively driven by respiratory (51.5%) and infectious (46.5%) conditions.
CONCLUSIONS: Infectious and respiratory diseases continue to represent the dominant burden on hospital capacity at the “Lviv Regional Clinical Infectious Diseases Hospital”. While the volume of circulatory disease patients is lower, their high resource consumption per capita highlights a specific area for effectiveness optimization. The persistence of COVID-19 admissions in 2025 underscores the need for continued infectious disease management strategies and cost evaluation.
Conference/Value in Health Info
2026-05, ISPOR 2026, Philadelphia, PA, USA
Value in Health, Volume 29, Issue S6
Code
EPH149
Topic
Epidemiology & Public Health
Topic Subcategory
Public Health
Disease
SDC: Infectious Disease (non-vaccine)